Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06685133 · ClinicalTrials.gov registry record
Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice
A clinical trial of Lung Cancer and Lung Nodule, sponsored by Noah Medical.
- Active
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT06685133 is a study of Lung Cancer and Lung Nodule that is active but no longer recruiting, run by Noah Medical. The registered enrollment target is 50 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06685133, a study of Lung Cancer and Lung Nodule, is active but no longer recruiting, sponsored by Noah Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.
Conditions Studied
Interventions
- DEVICE Robotic assisted bronchoscopy
Study Locations (2)
Tennessee
- CHI Memorial Hospital - Chattanooga
Virginia
- Inova Fairfax Medical Campus - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2027-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06685133
The ClinicalTrials.gov registry entry for NCT06685133 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Noah Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic assisted bronchoscopy is the first listed.
NCT06685133 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Virginia.
Frequently Asked Questions
What is clinical trial NCT06685133 about?
NCT06685133 is a clinical study titled "Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice". A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.
What is the current status of trial NCT06685133?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2024-11-08. Estimated completion is 2027-10-30.
What conditions does trial NCT06685133 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Nodule.
What interventions are being tested in trial NCT06685133?
The interventions under investigation include: Robotic assisted bronchoscopy (DEVICE).
Who is sponsoring clinical trial NCT06685133?
This trial is sponsored by Noah Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06685133 being conducted?
This trial has 2 study locations across Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.